Cefmenoxime therapy of serious bacterial infections.
The efficacy and safety of cefmenoxime was evaluated in 50 patients with serious bacterial infections. These included 26 pneumonias, 18 urinary tract infections, 2 soft tissue infections, 2 bacteremias, 1 renal abscess, and 1 peritonitis. A satisfactory clinical response was seen in 47 patients (94%...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1984
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185566/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6329082/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.4.510 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
